Cargando…
Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars
PURPOSE: The aim of this study was to describe the implementation and uptake of biosimilar trastuzumab in Denmark compared with other European countries. METHODS: European data for usage of trastuzumab was supplied by IQVIA™, using the MIDAS® dataset. A comparison was performed based on market share...
Autores principales: | Azuz, Samuel, Newton, Max, Bartels, Dorthe, Poulsen, Birgitte Klindt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440249/ https://www.ncbi.nlm.nih.gov/pubmed/34008071 http://dx.doi.org/10.1007/s00228-021-03155-4 |
Ejemplares similares
-
Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway
por: Håkonsen, Helle, et al.
Publicado: (2010) -
Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK
por: Gutzwiller, Florian S., et al.
Publicado: (2012) -
Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
por: Toverud, Else-Lydia, et al.
Publicado: (2010) -
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market
por: Mance, Diana, et al.
Publicado: (2016) -
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
por: Stawowczyk, Ewa, et al.
Publicado: (2016)